Synopsis:
In this symposia, presenters will review the latest evidence informing the use of Upadacitinib in rheumatologic conditions in the context of today’s treatment landscape and clinical practice.
Learnings from real world evidence and how this data can inform on key considerations for improving patient outcomes in clinical practice will also be discussed.
Agenda:
|
TBA mins |
Welcome Remarks: Introduction
|
|
TBA mins |
Presentation title TBA
Dr Eduardo Mysler and Dr Ryu Watanabe |
|
TBA mins |
Closing Remarks: Q&A and Discussion
All |
